Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filippo de Braud

Showing results (81-90 of 497) with videos related to

Pageof 50
Sort By:
Pharmacogenomics and Personalized Medicine|April 10, 2014
Targeted treatments in advanced renal cell carcinoma: focus on axitinibElena Verzoni, Paolo Grassi, Isabella Testa, et al.
Tumori|August 5, 2017
"Systemic strategy at the patient's service": a congress report on supportive care in oncologyFederico Nichetti, Riccardo Lobefaro, Filippo Pagani, et al.
The Annals of Thoracic Surgery|December 29, 2004
Extended pneumonectomy with partial resection of the left atrium, without cardiopulmonary bypass, for lung cancerLorenzo Spaggiari, Massimiliano D' Aiuto, Giulia Veronesi, et al.
Critical Reviews in Oncology/Hematology|July 28, 2004
Rectal cancerMaria Giulia Zampino, Roberto Labianca, Giordano Beretta, et al.
Critical Reviews in Oncology/Hematology|February 14, 2002
Bladder cancerFilippo de Braud, Massimo Maffezzini, Vito Vitale, et al.
Cancer Treatment Reviews|September 7, 2019
Collecting ducts carcinoma: An orphan disease. Literature overview and future perspectivesFilippo Pagani, Maurizio Colecchia, Pierangela Sepe, et al.
Anticancer Research|April 30, 2014
Sequential Tyrosine Kinase Inhibitors (TKIs) in metastatic renal cell carcinoma: results from a large cohort of patientsPamela Biondani, Elena Verzoni, Valter Torri, et al.
Future Oncology (London, England)|July 24, 2014
Targeted therapies in advanced renal cell carcinoma: the role of metastatic sites as a prognostic factorPaolo Grassi, Elena Verzoni, Luca Porcu, et al.
Therapeutic Advances in Medical Oncology|March 14, 2022
Prognostic impact of body mass index (BMI) in HER2+ breast cancer treated with anti-HER2 therapies: from preclinical rationale to clinical implicationsFrancesca Ligorio, Luca Zambelli, Giovanni Fucà, et al.
Thrombosis Research|April 13, 2016
Hypercoagulation screening as an innovative tool for risk assessment, early diagnosis and prognosis in cancer: the HYPERCAN studyAnna Falanga, Armando Santoro, Roberto Labianca, et al.
Pageof 50

Showing results (81-90 of 497) with videos related to

Sort By:
Pageof 50
Pharmacogenomics and Personalized Medicine|April 10, 2014
Targeted treatments in advanced renal cell carcinoma: focus on axitinibElena Verzoni, Paolo Grassi, Isabella Testa, et al.
Tumori|August 5, 2017
"Systemic strategy at the patient's service": a congress report on supportive care in oncologyFederico Nichetti, Riccardo Lobefaro, Filippo Pagani, et al.
The Annals of Thoracic Surgery|December 29, 2004
Extended pneumonectomy with partial resection of the left atrium, without cardiopulmonary bypass, for lung cancerLorenzo Spaggiari, Massimiliano D' Aiuto, Giulia Veronesi, et al.
Critical Reviews in Oncology/Hematology|July 28, 2004
Rectal cancerMaria Giulia Zampino, Roberto Labianca, Giordano Beretta, et al.
Critical Reviews in Oncology/Hematology|February 14, 2002
Bladder cancerFilippo de Braud, Massimo Maffezzini, Vito Vitale, et al.
Cancer Treatment Reviews|September 7, 2019
Collecting ducts carcinoma: An orphan disease. Literature overview and future perspectivesFilippo Pagani, Maurizio Colecchia, Pierangela Sepe, et al.
Anticancer Research|April 30, 2014
Sequential Tyrosine Kinase Inhibitors (TKIs) in metastatic renal cell carcinoma: results from a large cohort of patientsPamela Biondani, Elena Verzoni, Valter Torri, et al.
Future Oncology (London, England)|July 24, 2014
Targeted therapies in advanced renal cell carcinoma: the role of metastatic sites as a prognostic factorPaolo Grassi, Elena Verzoni, Luca Porcu, et al.
Therapeutic Advances in Medical Oncology|March 14, 2022
Prognostic impact of body mass index (BMI) in HER2+ breast cancer treated with anti-HER2 therapies: from preclinical rationale to clinical implicationsFrancesca Ligorio, Luca Zambelli, Giovanni Fucà, et al.
Thrombosis Research|April 13, 2016
Hypercoagulation screening as an innovative tool for risk assessment, early diagnosis and prognosis in cancer: the HYPERCAN studyAnna Falanga, Armando Santoro, Roberto Labianca, et al.
Pageof 50